Navigation Links
SIMULUS in Medical News

ATS Medical Announces FDA Clearance and First Implant of New ATS Simulus Semi-Rigid Annuloplasty Band

MINNEAPOLIS, July 6 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced FDA clearance and the first implant of the ATS Simulus(R) Semi-Rigid Annuloplasty Band. The Simulus Semi-Rigid Ann...

ATS Medical Announces FDA Clearance of the ATS Simulus Adjustable Annuloplasty Band

Expands Heart Valve Repair Product Portfolio MINNEAPOLIS, May 12 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced FDA clearance of the ATS Simulus(R) Adjustable Annuloplasty Band...

ATS Medical Receives FDA Clearance for ATS Simulus Semi-Rigid Annuloplasty Ring

Expands Heart Valve Repair Product Portfolio MINNEAPOLIS, Oct. 26 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced U.S. Food and Drug Administration (FDA) clearance f...

ATS Medical Announces Second Quarter 2009 Results

...cond quarter of 2008. The Company received regulatory approval of the simulus semi-rigid band in the second quarter. The semi-rigid band expands the Comp...lio in heart valve therapy is the ATS Simulus(R) annuloplasty product line. simulus products assist the surgeon in repairing a patient's native heart valve as ...

ATS Medical to Participate at Upcoming Investor Conferences

...ivotal clinical trials, and market commercialization. Completing the portfolio in heart valve therapy is the ATS Simulus(R) annuloplasty product line. simulus products assist the surgeon in repairing a patient's native heart valve as an alternative to replacement. Continuing ATS Medical's focus on serving th...

ATS Medical Announces Second Quarter 2009 Earnings Release Date and Conference Call

...ivotal clinical trials, and market commercialization. Completing the portfolio in heart valve therapy is the ATS Simulus(R) annuloplasty product line. simulus products assist the surgeon in repairing a patient's native heart valve as an alternative to replacement. Continuing ATS Medical's focus on serving th...

ATS Medical Announces First Use of the New ATS CryoMaze 10-S Probe

...ivotal clinical trials, and market commercialization. Completing the portfolio in heart valve therapy is the ATS Simulus(R) annuloplasty product line. simulus products assist the surgeon in repairing a patient's native heart valve as an alternative to replacement. Continuing ATS Medical's focus on serving th...

ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America

...rt valve repair market, will be showcased with special focus on the new ATS simulus Semi-Rigid Annuloplasty Ring. Exemplifying ATS's broad product offerin...io in heart valve therapy is the ATS Simulus(R) annuloplasty product line. simulus products assist the surgeon in repairing a patient's native heart valve as ...

ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting

...ill be showcased with special focus on the new ATS simulus Semi-Rigid Annuloplasty Ring. The simulus products easily accommodate the use of surgical cl...y is the ATS Simulus(R) annuloplasty product line. simulus products assist the surgeon in repairing a patient...

ATS Medical Appoints New Vice President of Marketing

...ivotal clinical trials, and market commercialization. Completing the portfolio in heart valve therapy is the ATS Simulus(R) annuloplasty product line. simulus products assist the surgeon in repairing a patient's native heart valve as an alternative to replacement. Continuing ATS Medical's focus on serving th...
SIMULUS in Biological Technology

ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons

...ill be showcased with special focus on the new ATS simulus Semi-Rigid Annuloplasty Ring. Paul Davis, MD, of ...on entitled "Physiological Correction with the ATS simulus Semi Rigid Ring". Hands-on demonstrations of ...y is the ATS Simulus(R) annuloplasty product line. simulus products assist the surgeon in repairing a patient...

ATS Medical Announces Formation of Cryoablation Surgical Advisory Board

...ivotal clinical trials, and market commercialization. Completing the portfolio in heart valve therapy is the ATS Simulus(R) annuloplasty product line. simulus products assist the surgeon in repairing a patient's native heart valve as an alternative to replacement. Continuing ATS Medical's focus on serving th...

ATS Medical Announces Record Quarterly Revenue and Gross Profit

...tributed to revenue growth of 28.0% in the first quarter of 2008 compared to Q4 2007 and 70.4% compared to the first quarter of 2007. The ATS simulus Flexible rings and bands are fast becoming the annuloplasty device of choice among surgeons performing surgical robotic mitral valve repair be...
Other Tags
(Date:5/29/2015)... 29, 2015 The Global Allopurinol ... study on the current state of the Allopurinol ... key statistics on the state of the industry ... direction for companies and individuals interested in the ... the industry including definitions, classifications, applications and industry ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Designed with ... teamed up to create an all new, exclusive line ... a formulated with the latest and greatest, high impact, ... proven to be effective. The 24/7 Series can be ... cross-fitters and even the casual fitness enthusiasts. There are ...
(Date:5/29/2015)... May 29, 2015 Javlin continues to ... U.S. headquarters and a larger team, with the intention ... CloverETL's market share in the U.S. and Canada. , ... Group, achieved significant growth in 2014 with its strongest ... premier data integration platform, CloverETL. To accelerate further progress ...
(Date:5/29/2015)... 2015 This is a professional ... the Naproxen industry.The report provides a basic overview ... industry chain structure. The Naproxen market ... development trends, competitive landscape analysis, and key regions ... well as manufacturing processes and cost structures are ...
(Date:5/29/2015)... Michigan (PRWEB) May 29, 2015 Vulvodynia ... and can cause significant physical, sexual, and psychological distress. ... altering disorder of Vulvodynia. The actual diagnosis is often ... in Endometriosis, they realize that this problem can be ... experiencing any of these symptoms, they need to schedule ...
Breaking Medicine News(10 mins):Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Growth of Data Integration Platform CloverETL Continues in North America 2Health News:Naproxen Market Analysis For Global & China Regions 2020 Research Forecasts 2
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
(Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, reminds investors ... Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA ... 5-7, 2015. The three-day conference is organized ... is speaking in is themed Global Fraud: Where is ...
(Date:4/20/2015)... Calif. , April 20, 2015 Huntington ... Gabriel Valley to implant a new miniaturized, wireless monitoring ... System is the first and only FDA-approved heart failure ... hospital admissions when used by physicians to manage heart ... sensor that is implanted in the pulmonary artery (PA) ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
Other Contents